Determinants of acceptance of cervical cancer screening in Dar es Salaam, Tanzania

BMC Public Health

Vibeke Rasch³  Myassa Dartell⁴  Britt Tersbol²  Twalib Ngoma¹  Julius Mwaiselage¹  Susanne Kjaer⁴  Crispin Kahesa¹ 

[1] Ocean Road Cancer Institute, Dar es Salaam, Tanzania;Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen K, Denmark;Department of Gynaecology and Obstetrics, Odense University Hospital, Denmark;Department of Virus, Lifestyle and Genes, Institute of Cancer and Epidemiology, Danish Cancer Society Gynaecologic Clinic Rigshospitalet, University of Copenhagen, Copenhagen K, Denmark

关键词: Tanzania;    Knowledge;    Demographic characteristics;    Screening acceptance;    Cervical cancer;   

Others  :  1162715
DOI  :  10.1186/1471-2458-12-1093

 received in 2012-04-09, accepted in 2012-11-17,  发布年份 2012

【 摘 要 】

Objective

To describe how demographic characteristics and knowledge of cervical cancer influence screening acceptance among women living in Dar es Salaam, Tanzania.

Methods

Multistage cluster sampling was carried out in 45 randomly selected streets in Dar es Salaam. Women between the ages of 25–59 who lived in the sampled streets were invited to a cervical cancer screening; 804 women accepted and 313 rejected the invitation. Information on demographic characteristics and knowledge of cervical cancer were obtained through structured questionnaire interviews.

Results

Women aged 35–44 and women aged 45–59 had increased ORs of 3.52 and 7.09, respectively, for accepting screening. Increased accepting rates were also found among single women (OR 2.43) and among women who had attended primary or secondary school (ORs of 1.81 and 1.94). Women who had 0–2 children were also more prone to accept screening in comparison with women who had five or more children (OR 3.21). Finally, knowledge of cervical cancer and awareness of the existing screening program were also associated with increased acceptance rates (ORs of 5.90 and 4.20).

Conclusion

There are identifiable subgroups where cervical cancer screening can be increased in Dar es Salaam. Special attention should be paid to women of low education and women of high parity. In addition, knowledge and awareness raising campaigns that goes hand in hand with culturally acceptable screening services will likely lead to an increased uptake of cervical cancer screening.

【 授权许可】

   
2012 Kahesa et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995, 87(11):796-802.
• [2]Kjaer SK, Chackerian B, van den Brule AJ, Svare EI, Paull G, Walbomers JM, Schiller JT, Bock JE, Sherman ME, Lowy DR, et al.: High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 2001, 10(2):101-106.
• [3]Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008. 2008.
• [4]Hakama M, Coleman MP, Alexe DM, Auvinen A: Cancer screening: evidence and practice in Europe 2008. Eur J Cancer 2008, 44(10):1404-1413.
• [5]Sankaranarayanan R, Budukh AM, Rajkumar R: Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ 2001, 79(10):954-962.
• [6]Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, Borras J, Parkin DM: International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer 2000, 86(3):429-435.
• [7]Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S: Trends in cancer incidence in Kyadondo County, Uganda, 1960–1997. Br J Cancer 2000, 82(9):1585-1592.
• [8]Lazcano-Ponce E, Palacio-Mejia LS, Allen-Leigh B, Yunes-Diaz E, Alonso P, Schiavon R, Hernandez-Avila M: Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology. Cancer Epidemiol Biomarkers Prev 2008, 17(10):2808-2817.
• [9]Sepulveda C, Prado R: Effective cervical cytology screening programmes in middle-income countries: the Chilean experience. Cancer Detect Prev 2005, 29(5):405-411.
• [10]Guidozzi F: Screening for cervical cancer. Obstet Gynecol Surv 1996, 51(4):247-252.
• [11]Palanuwong B: Alternative cervical cancer prevention in low-resource settings: Experiences of visual inspection by acetic acid with single-visit approach in the first five provinces of Thailand. Aust N Z J Obstet Gynaecol 2007, 47(1):54-60.
• [12]Denny L, Kuhn L, De Souza M, Pollack AE, Dupree W, Wright TC Jr: Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA 2005, 294(17):2173-2181.
• [13]Miller AB, Sankaranarayanan R, Bosch FX, Sepulveda C: Can screening for cervical cancer be improved, especially in developing countries? Int J Cancer 2003, 107(3):337-340.
• [14]Deodhar K, Sankaranarayanan R, Jayant K, Jeronimo J, Thorat R, Hingmire S, Muwonge R, Chiwate A, Deshpande R, Ajit D, et al.: Accuracy of concurrent visual and cytology screening in detecting cervical cancer precursors in rural India. Int J Cancer 2012, 131(6):E954-E962.
• [15]Dartell M: HPV infection and cervical cancer screening in HIV positive and HIV negative Tanzanian women. Denmark: University of Copenhagen, Department of International Health, Immunology and Microbiology; 2012. PhD thesis.
• [16]Ferlay JBF, Pisani P: Cancer Incidence, Mortality and Prevalence World Wide (version 2). Lyon, France: IARC Press; 2004.
• [17]Ngoma T, Muwonge R, Mwaiselage J, Kawegere J, Bukori P, Sankaranarayanan R: Evaluation of cervical visual inspection screening in Dar es Salaam, Tanzania. Int J Gynaecol Obstet 2010, 109(2):100-104.
• [18]Path : Report of an Africa Regional meeting on cervical cancer. 2010. http://www.rho.org/files/PATH_Africa_cxca_conf_report_2010.pdf webcite.
• [19]Sasieni P, Castanon A, Cuzick J: Effectiveness of cervical screening with age: population based case–control study of prospectively recorded data. BMJ 2009, 339:b2968.
• [20]Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX: Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case–control study. Lancet 2002, 359(9312):1093-1101.
• [21]Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, et al.: HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 2001, 84(9):1219-1226.
• [22]Autier P, Coibion M, Huet F, Grivegnee AR: Transformation zone location and intraepithelial neoplasia of the cervix uteri. Br J Cancer 1996, 74(3):488-490.
• [23]Bradley J, Risi L, Denny L: Widening the cervical cancer screening net in a South African township: who are the underserved? Health Care Women Int 2004, 25(3):227-241.
• [24]Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, Dillner J, Meijer CJ: Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008, 26(Suppl 10):K29-K41.
• [25]Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, Weigl B, Zhang WH, Peck RB, Li L, et al.: A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008, 9(10):929-936.
• [26]Kidanto HL, Kilewo CD, Moshiro C: Cancer of the cervix: knowledge and attitudes of female patients admitted at Muhimbili National Hospital, Dar es Salaam. East Afr Med J 2002, 79(9):467-475.
• [27]Francis SA, Battle-Fisher M, Liverpool J, Hipple L, Mosavel M, Soogun S, Mofammere N: A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health. Vaccine 2011, 29(47):8760-8765.
• [28]Mbamara SU, Ikpeze OC, Okonkwo JE, Onyiaorah IV, Ukah CO: Knowledge, attitude and practice of cervical cancer screening among women attending gynecology clinics in a tertiary level medical care center in southeastern Nigeria. J Reprod Med 2011, 56(11–12):491-496.
• [29]Mupepi SC, Sampselle CM, Johnson TR: Knowledge, attitudes, and demographic factors influencing cervical cancer screening behavior of Zimbabwean women. J Womens Health (Larchmt) 2011, 20(6):943-952.
• [30]Moving cancer up the global health agenda [editorial] Lancet 2010, 375(9731):2051.
• [31]IARC: Hand books of Cancer Prevention. Lyon, France: IARC pres; 2005.
• [32]Johnson BA, Khanna SK: Community health workers and home-based care programs for HIV clients. J Natl Med Assoc 2004, 96(4):496-502.
• [33]Nabudere H, Asiimwe D, Mijumbi R: Task shifting in maternal and child health care: an evidence brief for Uganda. Int J Technol Assess Health Care 2011, 27(2):173-179.